Cyclodextrin‐Derived Macromolecular Therapies for Inflammatory Diseases
Authors:
- 24 April 2025
- journal article
- review article
- Published by Wiley in Macromolecular Bioscience
- Vol. 25 (7) , e2400637
Abstract
Inflammation is an essential physiological defense mechanism against harmful stimuli, yet dysregulated inflammatory responses are closely associated with the pathogenesis of numerous acute and chronic diseases. Recent advances highlight the remarkable anti‐inflammatory potential of bioactive macromolecules, particularly cyclodextrins (CDs) and their engineered derivatives, which are emerging as promising therapeutic agents. This review systematically introduces different CDs and CD‐derived macromolecules that demonstrate anti‐inflammatory properties, with emphasis on their molecular mechanisms of action. Native CDs exhibit direct therapeutic effects through host‐guest interactions, enabling selective sequestration of pathogenic components such as cholesterol crystals and proteins that drive inflammatory cascades. Moreover, chemically modified CD derivatives incorporating functional groups demonstrate enhanced capabilities in neutralizing inflammatory mediators and modulating immune cell responses. This work further discusses the expanding therapeutic applications of these macromolecules across diverse inflammatory conditions, ranging from acute tissue injuries to chronic autoimmune disorders. Finally, this work critically analyzes the crucial challenges and emerging opportunities in translating CD‐based macromolecular therapies into clinical practice, addressing key considerations in biocompatibility, targeted delivery, and therapeutic efficacy optimization.Keywords
Funding Information
- National Natural Science Foundation of China (82102195, 32271451)
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ‐MSX1073)
This publication has 169 references indexed in Scilit:
- Nanotherapy‐Engineered Stem Cells Alleviate Myocardial Reperfusion Injury by Normalizing the Pathological Microenvironment and Promoting Cardiac RepairAdvanced Functional Materials, 2024
- Anti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin MaterialsAdvanced NanoBiomed Research, 2023
- Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatmentClinical and Translational Medicine, 2023
- Stem Cell‐Niche Engineering via Multifunctional Hydrogel Potentiates Stem Cell Therapies for Inflammatory Bone LossAdvanced Functional Materials, 2022
- Recognition and Removal of Amyloid‐β by a Heteromultivalent Macrocyclic Coassembly: A Potential Strategy for the Treatment of Alzheimer's DiseaseAdvanced Materials, 2020
- Cyclodextrin‐Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory DiseasesAdvanced Materials, 2019
- A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ ToxicityAdvanced Science, 2018
- Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and CytotoxicityChemistry – A European Journal, 2018
- Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C diseaseAnnals of Clinical and Translational Neurology, 2016
- Biocompatible Reactive Oxygen Species (ROS)‐Responsive Nanoparticles as Superior Drug Delivery VehiclesAdvanced Healthcare Materials, 2014